Skip to content
http://lifestyle.lmcordoba.com.ar/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cartesian Therapeutics, Inc.
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
June 9, 2026
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027
May 26, 2026
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 24, 2026
Cartesian Therapeutics Announces New Employment Inducement Grants
May 22, 2026
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 22, 2026
Cartesian Therapeutics Announces New Employment Inducement Grants
April 2, 2026
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
March 9, 2026
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
February 23, 2026
Cartesian Therapeutics Announces New Employment Inducement Grants
February 3, 2026